Immune Response to Full-Length Dystrophin Delivered to Dmd Muscle by a High-Capacity Adenoviral Vector

Author： Gilchrist S.C.   Ontell M.P.   Kochanek S.   Clemens P.R.  

Publisher： Elsevier

ISSN： 1525-0016

Source： Molecular Therapy, Vol.6, Iss.3, 2002-09, pp. : 359-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic Delivery of a High-Capacity Adenoviral Vector Expressing Mouse CTLA4Ig Improves Skeletal Muscle Gene Therapy

By Jiang Z.   Feingold E.   Kochanek S.   Clemens P.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 369-376

Elsevier

Access to resources Recommend Favorite

Improvements in Gene Therapy: Averting the Immune Response to Adenoviral Vectors

By Ritter T.  

BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 3-10

Adis International

Access to resources Recommend Favorite

Recombinant Full-Length Parathyroid Hormone (1-84): Profile Report

By Moen Marit D.   Scott Lesley J.  

BioDrugs, Vol. 21, Iss. 3, 2007-01 ,pp. : 205-208

Adis International

Access to resources Recommend Favorite

Improved system for helper-dependent adenoviral vector production

By Palmer D.   Ng P.  

Molecular Therapy, Vol. 8, Iss. 5, 2003-11 ,pp. : 846-852

Elsevier

Access to resources Recommend Favorite

Adenoviral Vector-Based Strategies for Cancer Therapy

By  

Current Drug Therapy, Vol. 4, Iss. 2, 2009-05 ,pp. : 117-138

Bentham Science Publishers

Access to resources Recommend Favorite